Aspen Australia

Aspen Australia commenced operations in May 2001 with a portfolio of products generating sales of around $10 million. After the acquisition of the Sigma pharmaceutical business in February 2011, current annualised sales are close to $900 million in Australia and New Zealand. Aspen Australia is also responsible for a growing business in a dozen countries in Asia accounting for about $83 million in in-market sales.

Besides marketing and distributing products owned by the Aspen Group, we also license in products from other companies, and are focused on meeting the needs of our licensors.